CMS Proposes To Remove Antidepressants, Immunosuppressants From Protected Drug Classes
CMS on Monday proposed to remove antidepressants and immunosuppressants from Part D protected drug classes, meaning that formularies could opt to include only lower-cost generic versions of the drugs -- a plan first reported by Inside Health Policy last Friday.
You've followed a link to an article or document on InsideHealthPolicy.com.
There are three ways you can access this content.
If you are an InsideHealthPolicy.com subscriber, or you have an active trial subscription, please login here:
Take A Trial Subscription
If you haven't already had a trial subscription to InsideHealthPolicy.com, you can sign up for one right now. Just click on the link below to get started -- you'll get full access for one month, including access to our newsletters, Inside CMS and FDA Week, plus daily news updates by e-mail and much, much more.
Sign up for a trial subscription.
Buy This Article
You can also buy this and other individual InsideHealthPolicy.com articles by going to the InsideHealthPolicy.com NewsStand. Articles are $5 apiece. We'll even give you your first download free.
Here's a direct link to this article on the NewsStand.